Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File | American Journal of Ophthalmology |
| 95 | 2011 |
Adverse effects of anticancer agents that target the VEGF pathway | Nature Reviews Clinical Oncology |
| 388 | 2009 |
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients | JAMA |
| 535 | 2008 |
Ranibizumab for neovascular age-related macular degeneration | New England Journal of Medicine |
| 2006 | |
Ranibizumab versus verteporfin for neovascular age-related macular degeneration | New England Journal of Medicine |
| 2006 |